Share this doc
Open By Default

Health CanadaReleased September 2020 • 508 pages
Request: All Health Canada reviewer reports and notes related to the New Drug Submission for Saxenda® (liraglutide) (DIN 02437899).
Report an issue with this document »

Want to support this project? Subscribe to the IJF today!

CreditsFounder: Matt Malone • Data acquisition and processing: Adam Soames, Ashley Desautels • Development: Daniel Nass, Sam Park, Martin Allen • Document hosting: DocumentCloud • Additional contributors
Get Involved
Contact us to contribute your documents, suggest an ATIP request or support the project.
Open By DefaultHomeMy documentsMethodologyFrequently asked questions